H. R. 331
IN THE HOUSE OF REPRESENTATIVES
January 9, 2007
Ms. Ginny Brown-Waite of Florida introduced the following bill; which was referred to the Committee on Veterans’ Affairs
To direct the Secretary of Veterans Affairs to conduct a study of the accuracy of expiration dates on certain prescription drugs maintained by the Department of Veterans Affairs.
Study of expiration dates on certain prescription drugs maintained by Department of Veterans Affairs
The Secretary of Veterans Affairs shall conduct a study of each candidate drug to—
evaluate the accuracy of the expiration date for such drug;
evaluate the feasibility of extending such expiration date; and
if such extension is feasible, recommend the period of such extension.
Assistance from the FDA
The Secretary of Veterans Affairs shall conduct the study required under subsection (a) in consultation with the Commissioner of Food and Drugs, who shall make available to the Secretary such records, and otherwise provide such assistance, as the Secretary may require for purposes of this section.
The Secretary of Veterans Affairs shall submit to Congress a report providing the results of the study required under subsection (a), including an estimate of the cost savings that may be achieved by implementing the recommendations of the study. Such report shall be submitted not later than one year after the date of the enactment of this Act.
Candidate drug defined
candidate drug means each
that is maintained in stock by the Department of Veterans Affairs;
that is subject to section 503(b)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353(b)(1));
for which the Department paid $3,000 or more for the stock of such product maintained by the Department; and
the stock of which has an expiration date that is not less than 12 months or more than 18 months before the date on which the product is to be studied under subsection (a).